{
    "nctId": "NCT03319069",
    "briefTitle": "Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer",
    "officialTitle": "A Prospective Phase 3 Clinical Trial Of Postmastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Locoregional control rate ipsilateral chest wall, axilla, supraclavicular and internal mammary nodal relapse.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Ipsilateral clinically diagnosed and histologically confirmed invasive breast cancer\n* Undergone total mastectomy and axillary dissection T 3-4 and/or 4 or more positive axillary lymph nodes.\n* Fit for chemotherapy ( if indicated) , endocrine therapy (if indicated), and postoperative irradiation.\n* Written informed concent.\n* C T3-4 , or C N2, or pathological positive axillary lymph nodes during mastectomy for patients who had received neoadjuvant chemotherapy or hormone therapy.\n* No supraclavicular or internal mammary nodes metastases.\n* No distant metastases .Enrollment date no more than 8 months after surgery or no more than 2 months after chemotherapy for patients who did't receive neoadjuvant therapy.\n* Enrollment date no more than 2 months after surgery for patients who had received neoadjuvant systemic therapy and did't need adjuvant chemotherapy.\n\nExclusion Criteria:\n\n* Patients who undergone previous irradiation to the ipsilateral chest wall and supraclavicular region\n* Previous or concurrent malignant other than non melanomatous skin cancer\n* Bilateral breast cancer.\n* Immediate or delayed ipsilateral breast cancer reconstruction.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}